Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$6.20
NASDAQ
Change (%)
 Stock is Up 0.01 (0.16%)
Volume
129,993
08/24/16      11:43 a.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
08/04/16OvaScience Reports Second Quarter 2016 Financial Results
— AUGMENT revenues increased 30% in 2Q16 compared to 1Q16 — — Strong financial position enables execution of corporate strategy — — Conference call today at 4:30 p.m. ET — WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 4, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported its second quarter 2016 financial results and highligh... 
Printer Friendly Version
07/28/16OvaScience to Host Second Quarter 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Jul. 28, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. EDT on Thursday, August 4, 2016 to discuss second quarter 2016 financial results and provide a general corporate update. The live call can be accessed by dialing +1-888-424-8151 for U.S. ... 
Printer Friendly Version
07/01/16Harald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience
— Begins Role with Strategic Focus on Accelerating Access in Key Markets; Increasing Patient Engagement; and Building Additional Real World Data —WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Harald F. Stock, Ph.D., has officially assumed the role of President and Chief Executive Officer, completing a planned leadership transition from Chief Execut... 
Printer Friendly Version
06/17/16OvaScience to Present at the JMP Securities Life Sciences Conference
WALTHAM, Mass.--(BUSINESS WIRE)--`OvaScienceSM (OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Company management will present at the JMP Securities Life Sciences Conference on Tuesday, June 21, 2016 at 11:30 am ET at the St. Regis New York. A live audio webcast of the presentation can be accessed by visiting the investor section of the Company's website at www... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources